Xtl Biopharma ADR (NQ: XTLB )

2.350 +0.110 (+4.91%)
Streaming Delayed Price Updated: 3:59 PM EDT, Nov 1, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
August 29, 2011
Form 6-K
Source: SEC/Edgar
August 29, 2011
Form 6-K
Source: SEC/Edgar
July 11, 2011
Form 6-K
Source: SEC/Edgar
June 05, 2011
Form 6-K
Source: SEC/Edgar
May 30, 2011
Form 6-K
Source: SEC/Edgar
May 30, 2011
Form 20-F
Source: SEC/Edgar
May 30, 2011
Form 6-K
Source: SEC/Edgar
April 20, 2011
Form 6-K
Source: SEC/Edgar
March 30, 2011
Form 6-K
Source: SEC/Edgar
March 24, 2011
Form 6-K
Source: SEC/Edgar
March 07, 2011
Form 6-K
Source: SEC/Edgar
November 30, 2010
Form 6-K
Source: SEC/Edgar
November 28, 2010
Form 6-K
Source: SEC/Edgar
September 27, 2010
Form 6-K
Source: SEC/Edgar
August 29, 2010
Form 6-K
Source: SEC/Edgar
August 03, 2010
Form 20-F
Source: SEC/Edgar
June 29, 2010
Form 6-K
Source: SEC/Edgar
June 01, 2010
Form 6-K
Source: SEC/Edgar
May 12, 2010
Form 6-K
Source: SEC/Edgar
March 25, 2010
Form 6-K
Source: SEC/Edgar
March 02, 2010
Form 6-K
Source: SEC/Edgar
January 19, 2010
Form 424B3
Source: SEC/Edgar
January 18, 2010
Form 6-K
Source: SEC/Edgar
January 14, 2010
Form 6-K
Source: SEC/Edgar
January 03, 2010
Form 6-K
Source: SEC/Edgar
November 30, 2009
Form 25-NSE
Source: SEC/Edgar
July 09, 2009
Form 6-K
Source: SEC/Edgar
June 11, 2009
Form CT ORDER
Source: SEC/Edgar
April 21, 2009
Form 6-K
Source: SEC/Edgar
April 15, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.